Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aegerion Pharmaceuticals, Inc reaffirms FY 2014 revenue guidance

Wednesday, 26 Feb 2014 07:00am EST 

Aegerion Pharmaceuticals, Inc:Reaffirms FY 2014 guidance.Expects FY 2014 global net product sales of between $190 mln and $210 mln.FY 2014 revenue of $206 mln - Thomson Reuters I/B/E/S. 

Related Company News

Company Quote

0.41 +1.90%
26 Dec 2014